多分支腔内修复胸腹及肾旁主动脉瘤的长期耐久性
本研究评估多分支腔内修复胸腹主动脉瘤(TAAA)和肾旁主动脉瘤的长期耐久性,纳入142例患者(538个分支),随访平均36个月。5年免于动脉瘤相关死亡率为91.1%,免于动脉瘤相关死亡或再干预率为76.8%,总体生存率49.1%。肾分支闭塞最常见(8.9%),但仅5例需永久透析。结论认为该技术安全、有效且耐久。
要点
- 多分支腔内修复TAAA和肾旁动脉瘤5年免于动脉瘤相关死亡率为91.1%。
- 肾分支闭塞是最常见晚期并发症(8.9%),但需永久透析者仅5例。
- 晚期再干预率13.3%,主要因肾分支闭塞或狭窄(7.7%)。
核心结论
- 采用轴向分支 cuff 的完全腔内修复治疗 TAAA 和肾旁主动脉瘤在长期随访中安全、有效且耐久。
研究设计与样本
- 回顾性单中心研究,纳入146例使用支架移植物行TAAA腔内修复的患者(共538个尾向自膨式分支),排除4例围术期死亡后分析142例(平均年龄73±8岁,女性35例[24.7%])。
- 随访包括临床检查和CT血管造影,于术后1个月、6个月、12个月及之后每年进行。
主要发现
- 平均动脉瘤直径67±9 mm;67例(47.2%)为Crawford I、II、III或V型TAAA,75例(52.8%)为IV型或肾旁动脉瘤。
- 平均随访36±28个月,3例(2.1%)在术后30天以上死于围术期并发症,另有4例动脉瘤相关死亡(各0.7%):动脉瘤破裂(无法治疗的I型内漏)、支架感染转开放手术后、肠系膜上动脉和腹腔分支闭塞后、双侧肾分支闭塞后。
- Kaplan-Meier分析显示5年免于动脉瘤相关死亡率为91.1%,免于动脉瘤相关死亡或再干预率为76.8%;5年总体生存率49.1%。
- 肾分支闭塞共23/256(8.9%),但仅5例患者需要永久透析。
临床怎么用
- 多分支腔内修复可用于TAAA和肾旁主动脉瘤,长期随访中动脉瘤相关死亡率较低。
- 肾分支闭塞虽常见但很少导致永久透析,仍需密切监测肾功能和分支通畅性。
- 晚期再干预主要针对肾分支闭塞或狭窄,需在随访中重点评估。
局限性
- 单中心回顾性研究,样本量有限(142例),随访时间平均36个月。
- 5年总体生存率仅49.1%,反映患者心肺合并症负荷高,可能影响耐久性评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of this study was to assess the durability of multibranched endovascular repair of thoracoabdominal aortic aneurysms (TAAAs) and pararenal aortic aneurysms by examining the rates of late-occurring (beyond 30 days) complications. METHODS: There were 146 patients who underwent endovascular TAAA repair using a stent graft, with a total of 538 caudally oriented self-expanding branches. Four patients died in the perioperative period and were excluded, leaving 142 patients (mean age, 73 ± 8 years; 35 [24.7%] women). Follow-up included clinical examination and computed tomography angiography at 1 month, 6 months, and 12 months and yearly thereafter. RESULTS: Mean aneurysm diameter was 67 ± 9 mm. Sixty-seven TAAAs (47.2%) were Crawford type I, II, III, or V; 75 (52.8%) were type IV or pararenal. Three patients (2.1%) died >30 days after operation from perioperative complications. During a mean follow-up of 36 months (±28 months), there were four additional aneurysm-related deaths: one (0.7%) as a result of aneurysm rupture in the presence of untreatable type I endoleak, one (0.7%) after conversion to open repair for stent graft infection, one (0.7%) after occlusion of superior mesenteric artery and celiac branches, and one (0.7%) due to bilateral renal branch occlusion. There was one additional open conversion for stent graft infection (0.7%). Nineteen patients (13.3%) underwent 20 reinterventions for late-occurring complications, including 11 (7.7%) for renal branch occlusion or stenosis, 1 (0.7%) for mesenteric branch stenosis, 4 (2.8%) for graft limb occlusion, 1 (0.7%) for type IB endoleak (distal stent graft migration), and 1 (0.7%) for type III endoleak (fabric erosion); 2 (1.4%) open conversions were performed for stent graft infection. There were no late type IA endoleaks. By Kaplan-Meier analysis, freedom from aneurysm-related death was 91.1% and freedom from aneurysm-related death or reintervention was 76.8% at 5 years. The 5-year overall survival rate of 49.1% reflects the high rate of cardiopulmonary comorbidity. Although renal branch occlusion (23 occlusions of 256 renal branches [8.9%]) was the most common late complication, only five patients required permanent dialysis. CONCLUSIONS: Total endovascular repair of TAAAs and pararenal aortic aneurysms using axially oriented cuffs is safe, effective, and durable in the long term.
引用
- Walker J, Kaushik S, Hoffman M, et al. Long-term durability of multibranched endovascular repair of thoracoabdominal and pararenal aortic aneurysms. J Vasc Surg. 2019. PMID: 30683193. doi:10.1016/j.jvs.2018.04.074
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。